Agrochemicals company Sharda croreopchem announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue from Operations: Rs 1,828.5 crore in Q4FY25 vs. Rs 1,312.1 crore in Q4FY24 — up 39% Gross Profit: Rs 544.0 crore in Q4FY25 vs. Rs 453.8 crore in Q4FY24 — up 20% Gross Profit Margin: 29.8% in Q4FY25 vs. 34.6% in Q4FY24 — down 480 bps EBITDA: Rs 351.8 crore in Q4FY25 vs. Rs 302.7 crore in Q4FY24 — up 16% EBITDA Margin: 19.2% in Q4FY25 vs. 23.1% in Q4FY24 — down 390 bps PAT: Rs 203.6 crore in Q4FY25 vs. Rs 143.5 crore in Q4FY24 — up 42% FY25 Financial Highlights: Revenue from Operations: Rs 4,319.9 crore in FY25 vs. Rs 3,163 crore in FY24 — up 37% Gross Profit: Rs 1,291.8 crore in FY25 vs. Rs 820.6 crore in FY24 — up 57% Gross Profit Margin: 29.9% in FY25 vs. 25.9% in FY24 — up 400 bps EBITDA: Rs 681.6 crore in FY25 vs. Rs 318.1 crore in FY24 — up 114% EBITDA Margin: 15.8% in FY25 vs. 10.1% in FY24 — up 570 bps PAT: Rs 304.4 crore in FY25 vs. Rs 31.9 crore in FY24 — up 854% Commenting on the Results, Ramprakash Bubna, Chairman and MD, said, “During Q4 FY25, the Company has witnessed a revival in demand with Revenues growing by 39% YoY to Rs 1,829 crore despite facing ongoing global challenges and sustained pricing pressures. This resurgence has translated into a strong operational and financial performance in Q4 FY25, reflecting resilience in our business model and the effectiveness of the initiatives taken. For FY25, Revenues grew by 37% YoY to Rs 4,320 crore. Gross profit margins expanded by 400 basis points to 29.8%, demonstrating our pricing resilience amid global headwinds. EBITDA more than doubled to Rs 682 crore, with EBITDA margins at 15.8%, aligning with our guidance. Agrochemical volumes saw a robust growth of 44% during the year. With raw material prices stabilising, we expect consistency in gross margins going ahead. Our strong pipeline of registrations reflects both our resilience and unwavering commitment to growth, laying a strong foundation for sustained future progress. We are confident on our ongoing plan to increase product registrations in FY26 with capex guidance of Rs 400-450 crore. For FY26, we aim to grow our topline by more than 15% while maintaining healthy EBITDA margins in the range of 15–18%.” Result PDF
Agrochemicals company Sharda Cropchem announced Q3FY25 results Revenue: Rs 929.3 crore compared to Rs 632.5 crore during Q3FY24, change 47%. Gross Profit: Rs 304.2 crore compared to Rs 165.6 crore during Q3FY24, change 84%. Gross Profit Margin: 32.7% for Q3FY25. EBITDA: Rs 156.6 crore compared to Rs 47.2 crore. EBITDA Margin: 16.9% for Q3FY25. PAT: Rs 31.1 crore compared to Rs 4.6 crore during Q3FY24. Ramprakash Bubna, Chairman and MD, said: “Despite the ongoing global headwinds and persistent pricing pressures, we have seen a revival in demand which has led to a strong performance in Q3FY25 Revenue in Q3FY25 increased by 47%, primarily driven by higher volumes. We saw volume growth across all regions, with Europe, NAFTA and LATAM being key drivers. Agrochemical volumes grew by 49.5% in Q3FY25. With raw material prices stabilising, we have managed to expand the gross margin by 660 bps to 32.7%. We have been working on cost optimization strategies and with operating leverage playing out, we have been able to improve our EBITDA Margins to 16.9% for the quarter. Our strong pipeline of registrations showcases our resilience and our commitment to growth which establishes a solid foundation for continued progress. We are confident on our ongoing plan to increase product registrations in FY25 with capex guidance of Rs 400-450 crore enabling us to meet FY25 guidance.” Result PDF
Agrochemicals company Sharda Cropchem announced Q2FY25 results Financial Highlights: Revenue: Rs 776.9 crore, compared to Rs 580.8 crore during the period Q2FY24, change 34%. Gross profit: Rs 214.7 crore, compared to Rs 145.5 crore during the period Q2FY24, change 48%. Gross profit Margin: 25.1%. EBITDA: Rs 84.4 crore, compared to Rs 37.7 crore during the period Q2FY24, change 125%. EBITDA margin: 6.5%. PAT: Rs 42.4 crore, compared to Rs -27.6 crore during the period Q2FY24. Business Highlights: Agrochemical Segment contributes 82%; Non-Agrochemical Segment contributes 18%. Overall Volumes have increased by 20.6% YoY in Q2FY25; Agrochemical volumes grew by 24.6% Agrochemical Segment contributes 84%; Non-Agrochemical Segment contributes 16%. Overall Volumes have increased by 30.3% YoY in H1FY25; Agrochemical volumes grew by 36.0%. Capex in H1FY25 stands at ~Rs. 155 crore. Product Registrations stand at 2,934 with 1,034 applications globally pending at various stages as on 30th September 2024. We remain a debt free company with cash, bank & liquid investments of Rs. 656 crore. Ramprakash Bubna, Chairman and MD, said: “Despite the global industry challenges, including subdued demand and pricing pressures, we have delivered strong performance in Q2 and H1FY25 compared to last year. Revenue in Q2FY25 increased by 34%, and H1FY25 by 28%, primarily driven by higher volumes and a gradual price increase. We saw volume growth across all regions, with Europe and NAFTA being key contributors. Agrochemical volumes grew by 24.6% in Q2FY25 and by 36.0% in H1FY25. We are optimistic about improving gross margins moving forward. Our extensive pipeline of registrations showcases our resilience and our commitment to growth. To drive sustainable growth, we intensify our focus on operational efficiencies. This enhances profitability and organizational agility, ensuring a strong foundation for future growth. We are happy to emphasize our ongoing plan to increase product registrations in FY25 with capex guidance of Rs. 400-450 crore is on track driving revenue growth, improved competitiveness, and increased customer satisfaction.” Result PDF